These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Biological investigation in hyperthyroidism]. Guinet P. Cah Med; 1972 Dec 30; 13(17):1235-42. PubMed ID: 4121374 [No Abstract] [Full Text] [Related]
3. Dissociation of serum LATS content and thyroid suppressibility during treatment of hyperthyroidism. Chopra IJ, Solomon DH, Johnson DE, Chopra U, Fischer DA. J Clin Endocrinol Metab; 1970 Apr 30; 30(4):524-8. PubMed ID: 5435290 [No Abstract] [Full Text] [Related]
6. "Suppressible" and "non-suppressible" thyroidal radioiodine uptake of hyperthyroid glands. Rohner R, König MP, Bucher HJ, Studer H. Helv Med Acta Suppl; 1970 Jun 30; ():Suppl 50:119. PubMed ID: 4108536 [No Abstract] [Full Text] [Related]
7. Long-acting thyroid stimulator (LATS) and immunofluorescent studies in patients with pretibial myxoedema. From E, Diederichsen H, Heydenreich G, Nielsen OS. Dan Med Bull; 1973 Dec 30; 20(6):188-91. PubMed ID: 4591336 [No Abstract] [Full Text] [Related]
8. [Clinical assessment of a new T3 test (Trilute) for investigation of thyroid function]. Siersbaek-Nielsen K, Kolendorf K, Rogowski P, Hansen JM. Ugeskr Laeger; 1972 May 29; 134(22):1163-5. PubMed ID: 5045784 [No Abstract] [Full Text] [Related]
9. [Suppression of the thyroid gland using l-triiodothyronine. Dependence on function, iodine uptake, size of the thyroid gland and age]. Heinze HG, Pabst HW, Sonntag A. Munch Med Wochenschr; 1968 Aug 23; 110(34):1875-84. PubMed ID: 5695744 [No Abstract] [Full Text] [Related]
10. [Studies on the resin sponge uptake of 131I-triiodothyronine as a test of thyroid function. I. Fundamental studies on the resin sponge uptake of 131I-triiodothyronine]. Nakamura I. Kumamoto Igakkai Zasshi; 1970 Mar 25; 44(3):165-77. PubMed ID: 4193831 [No Abstract] [Full Text] [Related]
11. A rapid (48 hours) thyroid suppression test using a single oral dose of 100 micrograms of triiodothyronine. Ikkos DG, Lakka-Papadodima E, Ntalles C. Nucl Med (Stuttg); 1973 Nov 15; 12(3):202-17. PubMed ID: 4788275 [No Abstract] [Full Text] [Related]
12. Correlation between long-acting thyroid stimulator protector level and thyroid 131-I uptake in thyrotoxicosis. Adams DD, Kennedy TH, Stewart RD. Br Med J; 1974 Apr 27; 2(5912):199-201. PubMed ID: 4406686 [Abstract] [Full Text] [Related]
13. Diagnosis of Graves' ophthalmopathy without hyperthyroidism: long-acting thyroid stimulator (LATS) determination as laboratory adjunct. Gharib H, Mayberry WE. Mayo Clin Proc; 1970 Jun 27; 45(6):444-9. PubMed ID: 4193249 [No Abstract] [Full Text] [Related]
17. [Absent biological demonstration of "long-acting thyroid stimulator" (LATS) in endemic euthyroid iodine deficiency goiters]. Stelzer M, Mertz DP. Munch Med Wochenschr; 1969 Jun 06; 111(23):1306-9. PubMed ID: 5820134 [No Abstract] [Full Text] [Related]
18. [Diagnostic value of the early triiodothyronine suppression test in thyrotoxicosis]. Wiggers S, Nielsen ES. Ugeskr Laeger; 1970 Oct 29; 132(44):2067-71. PubMed ID: 5507467 [No Abstract] [Full Text] [Related]
20. [Determination of thyrotropic hormone and long acting thyroid stimulator by the McKenzie technique. Critical study of the method]. Bonnyns M. Rev Fr Etud Clin Biol; 1968 Nov 29; 13(9):845-52. PubMed ID: 5709509 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]